Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity

被引:0
|
作者
Hoeller, U
Biertz, I
Flinzberg, S
Tribius, S
Schmelzle, R
Alberti, W
机构
[1] Vivantes Klinikum Neukolln, Klin Strahlentherapie & Radioonkol, Dept Radiotherapy, D-12351 Berlin, Germany
[2] Univ Hosp Hamburg Eppendorf, Dept Radiotherapy & Radiooncol, Hamburg, Germany
[3] Univ Hosp Hamburg Eppendorf, Dept Dent Oral & Maxillofacial Surg, Hamburg, Germany
关键词
head-and-neck cancer; hyperfractionated radiotherapy; surgery; late effects;
D O I
10.1007/s00066-006-1472-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the outcome of hyperfractionated-accelerated radiotherapy and subsequent planned primary tumor resection and radical neck dissection in locally advanced tumors of the oral cavity. Patients and Methods: This retrospective analysis evaluates 126 subsequent patients who were treated between 1988 and 1997 for locally advanced tumors of the oral cavity (with extension into the oropharynx in 17 patients), 34 (27%) AJCC stage III and 92 (73%) stage IV. Primary tumor and nodal metastases were irradiated with 1.4 Gy bid to a median total dose of 72.8 Gy (range 58.8-75.6 Gy). Then, planned radical surgery of the primary site according to the initial tumor extent and cervical nodes was performed. Median follow-up of living patients was 6 years (range 1-11 years). Results: 4 weeks after radiotherapy, 14 patients (11%) had complete tumor remission, 92 (73%) partial remission, 15 (12%) no change, and five (4%) progressive disease. Complete resection was achieved in 117 (93%) patients (nine incomplete resections). 5-year locoregional control rate was 62 +/- 9%, overall survival 36 +/- 9%. Surgery-related morbidity occurred in 42 patients (33%; mainly delayed wound healing and fistulae), overall severe treatment-related morbidity in 46 patients (36%). 24/84 relapse-free patients (29%) required a percutaneous gastrostomy or nasal tube >= 1 year after therapy. Conclusion: In this study, the outcome of combined curative radiotherapy and planned surgery of the primary tumor and neck nodes was comparable to reported results of hyperfractionated radiotherapy with or without salvage surgery of the neck nodes with respect to locoregional control and overall survival. Planned surgery carries a substantial risk of morbidity and seems to offer no benefit in comparison to salvage surgery of the neck nodes only. Therefore, salvage surgery is preferred.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [1] Hyperfractionated-accelerated Radiotherapy before Surgery for Patients with locally advanced Rectal Cancer
    Geinitz, H.
    Feichtinger, J.
    Kocik, L.
    Track, C.
    Kaufmann, J.
    Weingartner, T.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S72 - S72
  • [2] Hyperfractionated-Accelerated Radiotherapy Followed by Radical Surgery in Locally Advanced Tumors of the Oral CavityHyperfraktioniert-akzelerierte Strahlentherapie mit anschließender radikaler Resektion bei lokal fortgeschrittenen Mundhöhlentumoren
    Ulrike Hoeller
    Iris Biertz
    Sebastian Flinzberg
    Silke Tribius
    Reiner Schmelzle
    Winfried Alberti
    [J]. Strahlentherapie und Onkologie, 2006, 182 (3) : 157 - 163
  • [3] Hyperfractionated-accelerated radiotherapy in locally advanced breast cancer: Fifteen-year results
    Carmona-Vigo, R.
    Henriquez Hernandez, L. A.
    Pinar Sedeno, B.
    Lloret Saez-Bravo, M.
    Lara Jimenez, P. C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S378 - S378
  • [4] Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors
    Thomas Kuhnt
    Axel Becker
    Marc Bloching
    Johannes Schubert
    Gunther Klautke
    Rainer Fietkau
    Juergen Dunst
    [J]. Medical Oncology, 2006, 23 : 325 - 333
  • [5] Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors
    Kuhnt, Thomas
    Becker, Axel
    Bloching, Marc
    Schubert, Johannes
    Klautke, Gunther
    Fietkau, Rainer
    Dunst, Juergen
    [J]. MEDICAL ONCOLOGY, 2006, 23 (03) : 325 - 333
  • [6] Accelerated hyperfractionated radiotherapy for locally advanced cervix cancer
    MacLeod, C
    Bernshaw, D
    Leung, S
    Narayan, K
    Firth, I
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03): : 519 - 524
  • [7] Accelerated Hyperfractionated Radiotherapy for Locally Advanced Uterine Cervix Cancers
    Seo, Young Seok
    Cho, Chul Koo
    Yoo, Seong Yul
    Kim, Mi Sook
    Yang, Kang Mo
    Yoo, Hyung Jun
    Choi, Chul Won
    Lee, Kyung Hee
    Lee, Eui Don
    Rhu, Sang Young
    Choi, Suck Chul
    Kim, Moon Hong
    Kim, Beob Jong
    [J]. RADIATION ONCOLOGY JOURNAL, 2008, 26 (01): : 24 - 34
  • [8] Preoperative hyperfractionated accelerated radiotherapy in locally advanced rectal cancer
    Notter, M
    Bühlmann, M
    Hueber, C
    Schlumpf, R
    Bodis, S
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 133 - 133
  • [9] Hyperfractionated accelerated radiotherapy in locally advanced head and neck cancers
    Yoney, Adnan
    Akboru, Halil
    Kandemir, Ozge
    Unsal, Mustafa
    [J]. ONKOLOGIE, 2007, 30 (10): : 479 - 484
  • [10] Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer
    Haugen, H
    Johansson, KA
    Mercke, C
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (01): : 109 - 119